Skip to content
10-Q

Quarterly Report

INNOVATION PHARMACEUTICALS INC.

0001477932-23-003414

← back to feed
Filed
May 15, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Operating Cash Flow Q3 2023 · Mar 31, 2023 −$1.74M
Operating Cash Flow Q3 2023 · Mar 31, 2022 −$5.32M
Cash And Equivalents Q3 2023 · Mar 31, 2023 $1.94M
Cash And Equivalents Q3 2023 · Jun 30, 2022 $3.81M
Stockholders Equity Q3 2023 · Mar 31, 2023 $2.72M
Stockholders Equity Q3 2023 · Dec 31, 2022 $3.08M
Stockholders Equity Q3 2023 · Sep 30, 2022 $3.42M
Stockholders Equity Q3 2023 · Jun 30, 2022 $4.73M
Stockholders Equity Q3 2023 · Mar 31, 2022 $5.82M
Stockholders Equity Q3 2023 · Dec 31, 2021 $6.95M
Stockholders Equity Q3 2023 · Sep 30, 2021 $8.3M
Stockholders Equity Q3 2023 · Jun 30, 2021 $7.51M
Current Liabilities Q3 2023 · Mar 31, 2023 $4.82M
Current Liabilities Q3 2023 · Jun 30, 2022 $4.81M
Total Liabilities Q3 2023 · Mar 31, 2023 $5.28M
Total Liabilities Q3 2023 · Jun 30, 2022 $5.65M
Current Assets Q3 2023 · Mar 31, 2023 $1.94M
Current Assets Q3 2023 · Jun 30, 2022 $3.95M
Total Assets Q3 2023 · Mar 31, 2023 $7.99M
Total Assets Q3 2023 · Jun 30, 2022 $10.38M
Sga Expense Q3 2023 · Mar 31, 2023 $144K
Sga Expense Q3 2023 · Mar 31, 2023 $626K
Sga Expense Q3 2023 · Mar 31, 2022 $320K
Sga Expense Q3 2023 · Mar 31, 2022 $771K
Rd Expense Q3 2023 · Mar 31, 2023 $323K
Rd Expense Q3 2023 · Mar 31, 2023 $1.16M
Rd Expense Q3 2023 · Mar 31, 2022 $931K
Rd Expense Q3 2023 · Mar 31, 2022 $4.12M
Net Income Q3 2023 · Mar 31, 2023 −$698K
Net Income Q3 2023 · Mar 31, 2023 −$2.49M
Net Income Q3 2023 · Dec 31, 2022 −$361K
Net Income Q3 2023 · Sep 30, 2022 −$1.43M
Net Income Q3 2023 · Mar 31, 2022 −$1.49M
Net Income Q3 2023 · Mar 31, 2022 −$5.42M
Net Income Q3 2023 · Dec 31, 2021 −$1.87M
Net Income Q3 2023 · Sep 30, 2021 −$2.06M
Operating Income Q3 2023 · Mar 31, 2023 −$679K
Operating Income Q3 2023 · Mar 31, 2023 −$2.44M
Operating Income Q3 2023 · Mar 31, 2022 −$1.46M
Operating Income Q3 2023 · Mar 31, 2022 −$5.5M
Revenue Q3 2023 · Mar 31, 2023 $0
Revenue Q3 2023 · Mar 31, 2023 $0
Revenue Q3 2023 · Mar 31, 2022 $0
Revenue Q3 2023 · Mar 31, 2022 $0